首页> 外文OA文献 >EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus acidophilus BCCM/LMG P-18806, Lactobacillus delbrueckii BCCM/LMG P-18805 and Streptococcus thermophilus BCCM/LMG P-18807 and reduction of gastro-intestinal discomfort (ID 2946, 2951, 2974), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 2946, 2951, 2974), improved lactose digestion (ID 2946, 2951, 2974), and reduction in numbers of circulating CD34+ cells (ID 2947, 2952, 2975) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
【2h】

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus acidophilus BCCM/LMG P-18806, Lactobacillus delbrueckii BCCM/LMG P-18805 and Streptococcus thermophilus BCCM/LMG P-18807 and reduction of gastro-intestinal discomfort (ID 2946, 2951, 2974), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 2946, 2951, 2974), improved lactose digestion (ID 2946, 2951, 2974), and reduction in numbers of circulating CD34+ cells (ID 2947, 2952, 2975) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

机译:EFsa饮食产品,营养和过敏专家组(NDa);关于与嗜酸乳杆菌BCCm / LmG p-18806,德氏乳杆菌BCCm / LmG p-18805和嗜热链球菌BCCm / LmG p-18807联合使用以及减少胃肠不适的健康声明的科学意见(ID 2946, 2951,2974),减少潜在致病性胃肠道微生物(ID 2946,2951,2974),改善乳糖消化(ID 2946,2951,2974),并减少循环CD34 +细胞数量(ID 2947,2952,2975)(根据第(EC)1924/2006号条例第13(1)条进一步评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to provide a scientific opinion on health claims pursuant to Article 13 of Regulation (EC) No 1924/2006 in the framework of further assessment related to a combination of Lactobacillus acidophilus BCCM/LMG P-18806, Lactobacillus delbrueckii BCCM/LMG P-18805 and Streptococcus thermophilus BCCM/LMG P-18807 and reduction of gastro-intestinal discomfort, decreasing potentially pathogenic gastro-intestinal microorganisms, improved lactose digestion, and reduction in numbers of circulating CD34+ cells. The food constituent that is the subject of the health claim, a combination of L. acidophilus BCCM/LMG P-18806, L. delbrueckii BCCM/LMG P-18805 and S. thermophilus BCCM/LMG P-18807, is sufficiently characterised. The evidence provided did not establish that the proposed claimed effect, reduction in numbers of circulating CD34+ cells, is a beneficial physiological effect. The claimed effect, reduction of gastro-intestinal discomfort, is a beneficial physiological effect for the general population. The claimed effect, a decrease in potentially pathogenic gastro-intestinal microorganisms, might be a beneficial physiological effect for the general population. The claimed effect, improved lactose digestion, is a beneficial physiological effect for individuals with lactose maldigestion. No human intervention studies were provided from which conclusions could be drawn for the scientific substantiation of the above-mentioned claims. On the basis of the data provided, the Panel concludes that a cause and effect relationship has not been established between the consumption of a combination of L. acidophilus BCCM/LMG P-18806, L. delbrueckii BCCM/LMG P-18805 and S. thermophilus BCCM/LMG P-18807 and reduction of gastro-intestinal discomfort, decreasing potentially pathogenic gastro-intestinal microorganisms, and improved lactose digestion.
机译:应欧盟委员会的要求,要求营养产品,营养和过敏问题专家组(NDA)根据1924/2006号法规(EC)第13条在有关进一步评估的框架内就健康声明提供科学意见嗜酸乳杆菌BCCM / LMG P-18806,德氏乳杆菌BCCM / LMG P-18805和嗜热链球菌BCCM / LMG P-18807的组合,可减轻胃肠道不适感,减少潜在的致病性胃肠道微生物,改善乳糖消化,和减少循环中CD34 +细胞的数量。作为健康要求主题的食品成分,嗜酸乳杆菌BCCM / LMG P-18806,德氏乳杆菌BCCM / LMG P-18805和嗜热链球菌BCCM / LMG P-18807的组合具有足够的特征。所提供的证据并未证明所要求的效应,即循环中CD34 +细胞数量的减少,是有益的生理效应。所要求的效果,即减少肠胃不适,对于一般人群是有益的生理效果。所要求的效果,即潜在致病性胃肠道微生物的减少,可能是对一般人群有益的生理效果。所要求的作用,即改善的乳糖消化,对于患有乳糖消化不良的个体是有益的生理作用。没有提供任何人为干预研究,可以从中得出结论以科学证明上述主张。根据提供的数据,小组得出结论,食用嗜酸乳杆菌BCCM / LMG P-18806,德氏乳杆菌BCCM / LMG P-18805和S的组合之间尚未建立因果关系。嗜热菌BCCM / LMG P-18807和减少肠胃不适,减少潜在致病性肠胃微生物并改善乳糖消化。

著录项

  • 作者

    Tetens Inge;

  • 作者单位
  • 年度 2012
  • 总页数
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号